Our team of experts with a broad background cover a variety of services with a focus on CMC biologics and Quality Assurance. We have a combined experience from various managerial positions in the pharmaceutical and biotech industry as well as years of work with consultancy assignments.
With more than 20 years in the pharmaceutical and biotech industry, Andreas has solid experience in a wide range of areas.
He has held various positions at Pharmacia & Upjohn, Biovitrum and Sobi. and his experiences include CMC process development, project and line management, strategic manufacturing sourcing, technology transfer and clinical and commercial manufacturing.
Andreas has studied business economics and chemistry technology at Örebro University and Mälardalen University, respectively. He is one of the founders of Phase2Phase.
Phone: +46 (0) 708 888 159
During close to 20 years in the biopharmaceutical industry, Svante has gained a solid experience of process development, validation, project management, tech transfer, CMC, and commercial manufacturing. He has, among other things, held positions as project manager and process validation lead at Biovitrum, ten years as section manager within upstream manufacturing at Sobi, and as head of production support at Octapharma. He is the founder and senior consultant of Valient Consulting AB and one of the founders of Phase2Phase.
Svante holds a Master of Science degree in Molecular Biotechnology from Uppsala University.
Phone: +46 (0) 709 999 323
Josefine holds a MSc in Biotechnology from the Royal Institute of Technology in Stockholm and since then has gained a solid experience from Biologics Upstream Manufacturing, both from process development and commercial operations and quality assurance. Josefine also has years of experience from the consultancy space where sha has had several assignments with a broad range within biopharmaceuticals as well as the med tech industry.
Phone: +46 (0) 767 777 125
Maria Krook, holding a PhD from Karolinska Institute, is a Senior Quality Professional with in-depth understanding of manufacture and testing of Biologics according to applicable GMP requirements. She is an experienced manager and is currently working as Senior Quality Specialist and Qualified Person performing release of DS, DP and packaged and labelled IMP for use in clinical trials. Previous to that she worked as Director of Quality Assurance and QP at Cobra Biologics and also has several years of experience within different areas of Analytical Development at Astra Zeneca.
Phone: +46 (0) 703 330 893
Annica is a senior professional with more than 20 years’ experience within the biopharmaceutical industry, and holds a Master of Science in Chemical Engineering.
Annica’s experience ranges from project management, to leadership within Upstream GMP biopharmaceutical manufacturing, to supply chain and trade & transport compliance. During the last 10 years, before joining Phase2Phase, Annica held a position as Trade Compliance Director at Sobi, where she played an instrumental part in establishing a trade compliance organization from scratch.
Phone: +46 (0) 736 735 462
Mats is a senior professional with more than 25 years of experience in the biopharmaceutical industry. He has significant expertise in strategic development, cell culture production, purification and analytics of vaccines, cell and gene therapies and other ATMPs.
Prior to joining Phase2Phase he was the Applications Director at Cytiva/GE Healthcare and supported biopharma companies globally to produce new therapies more efficiently. He has held positions as scientist, team manager and VP at Pharmacia, AstraZeneca and smaller biotech companies. He has also managed the teams for Cell line and Upstream Process Development for monoclonal antibodies at a major pharma company.
Mats holds a PhD from the Karolinska Institute in Stockholm and post-doc training at Imperial College School of Medicine in London.
Phone: +46 (0) 761 111 046
Joke has more than 15 years of experience in the pharmaceutical industry. Prior to joining Phase2Phase she was Team Manager of the Downstream Development team at the CDMO Cobra Biologics. There she gained experience within the development of monoclonal antibodies, biosimilars and other recombinant (fusion-) proteins. Joke holds a PhD in Biochemistry from the Royal Institute of Technology in Stockholm Sweden.
Phone: +46 (0) 761 111 528